These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19715799)
1. Metastatic activity and chemotherapy resistance in human pancreatic cancer--influence of cancer stem cells. Ischenko I; Seeliger H; Jauch KW; Bruns CJ Surgery; 2009 Sep; 146(3):430-4. PubMed ID: 19715799 [No Abstract] [Full Text] [Related]
2. Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer. Simeone DM Clin Cancer Res; 2008 Sep; 14(18):5646-8. PubMed ID: 18794070 [TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells: a step toward the cure. Boman BM; Wicha MS J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956 [No Abstract] [Full Text] [Related]
4. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353 [TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells in head and neck squamous cell cancer. Prince ME; Ailles LE J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966 [TBL] [Abstract][Full Text] [Related]
6. Biology and clinical applications of pancreatic cancer stem cells. Abel EV; Simeone DM Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment. Fitzgerald TL; McCubrey JA Adv Biol Regul; 2014 Sep; 56():45-50. PubMed ID: 24925031 [TBL] [Abstract][Full Text] [Related]
8. New frontiers in pancreatic cancer research. Khan GN; di Magliano MP; Simeone DM Surg Oncol Clin N Am; 2010 Apr; 19(2):431-51. PubMed ID: 20159524 [TBL] [Abstract][Full Text] [Related]
11. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer. El Maalouf G; Le Tourneau C; Batty GN; Faivre S; Raymond E Cancer Treat Rev; 2009 Apr; 35(2):167-74. PubMed ID: 19027240 [TBL] [Abstract][Full Text] [Related]
15. Liver cancer stem cells: implications for a new therapeutic target. Lee TK; Castilho A; Ma S; Ng IO Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415 [TBL] [Abstract][Full Text] [Related]
16. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. van der Flier LG; Haegebarth A; Stange DE; van de Wetering M; Clevers H Gastroenterology; 2009 Jul; 137(1):15-7. PubMed ID: 19450592 [No Abstract] [Full Text] [Related]
17. Is the cancer stem cell population "a player" in multi-drug resistance? Drewa T; Styczynski J; Szczepanek J Acta Pol Pharm; 2008; 65(4):493-500. PubMed ID: 19051593 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer stem cells: initiating a new sort of thinking. Herschkowitz JI Dis Model Mech; 2010; 3(5-6):257-8. PubMed ID: 20427552 [No Abstract] [Full Text] [Related]
19. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine. Winquist RJ; Boucher DM; Wood M; Furey BF Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800 [TBL] [Abstract][Full Text] [Related]
20. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Fujisawa T; Joshi B; Nakajima A; Puri RK Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]